๐ŸŽ—๏ธ OncologyInjection (SC)

    Elrexfio

    Elranatamab

    BCMA-directed bispecific T-cell engager for relapsed/refractory multiple myeloma.

    Form

    Injection (SC)

    Uses

    1

    Side effects

    5

    Category

    Oncology

    01

    What is Elrexfio used for?

    • Relapsed/refractory multiple myeloma
    02

    Elranatamab side effects

    Common side effects of Elranatamab include:

    Cytokine release syndrome
    Infections
    ICANS (neurotoxicity)
    Neutropenia
    Anemia
    CommonModerateLess common
    03

    Elranatamab warnings & precautions

    • Black box: CRS and neurologic toxicity
    • REMS required. Step-up dosing
    • Serious infections

    Loading FDA dataโ€ฆ

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Elrexfio in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.